Jackie Veivia-Panter is a distinguished leader in the pharmaceutical and cell and gene therapy industries, with over 30 years of expertise in quality assurance. As a dedicated member of the Parenteral Drug Association (PDA) for more than 20 years, Jackie has significantly shaped the organization’s initiatives. Her contributions include serving on regulatory commenting teams, the PDA-FDA Joint Regulatory Conference planning committee, and as chair of both the Data Integrity and CDMO workshops. She has also held leadership roles as Vice Chair, Chair, and Past Chair of the Regulatory and Quality Advisory Board (RAQAB) and was a member of the Advanced Therapy Medicinal Products Advisory Board (ATMP AB).

In the past year, Jackie faced a personal challenge with metastatic breast cancer, which temporarily limited her active participation in PDA. This experience has enriched her perspective, providing a profound understanding of the patient journey which she now integrates into her professional work. Jackie’s LinkedIn profile (Jackie Veivia-Panter) reflects her extensive experience and unwavering commitment to advancing pharmaceutical science and regulatory excellence through collaboration and innovation.